PetCaseFinder

Peer-reviewed veterinary case report

Copper poisoning in Bedlington terriers linked to several gene changes

By Haywood, Susan et al.·Published in The Veterinary record·2023·School of Veterinary Science, United Kingdom·View original on PubMed

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: Copper toxicosis in Bedlington terriers is associated with multiple independent genetic variants.

Species:
dog

Plain-English summary

A group of Bedlington terriers was found to have copper toxicosis, a condition where excess copper builds up in the liver, leading to serious health issues. Researchers discovered that while a specific genetic deletion was present in some affected dogs, it is no longer the main cause of the disease. Instead, a different genetic mutation (ATP7B) was more commonly found in Bedlington terriers with copper toxicosis compared to unaffected dogs. This suggests that there are multiple genetic factors involved in this condition. If your Bedlington terrier shows signs of liver problems, it's important to discuss genetic testing and treatment options with your veterinarian.

People also search for: Bedlington terrier copper toxicosis symptoms · liver problems in Bedlington terriers · genetic testing for dog liver disease

Abstract

BACKGROUND: Bedlington terrier copper toxicosis (CT) is due to a homozygous exon deletion in COMMD1. CT also occurs in Bedlingtons lacking this deletion. An association with two ABCA12 single nuceotide polymorphism (SNP) splice variants was reported. Labrador retriever CT is associated with a missense mutation in ATP7B, and with a protective mutation in ATP7A. METHODS: Liver and DNA samples from 24 affected and 10 unaffected Bedlingtons were assessed for copper and genetic variants. Allelic frequencies were compared. The ATP7B mutation frequency was investigated in 144 dogs of other breeds. RESULTS: The ABCA12 SNPs showed no differences between groups. The COMMD1 deletion was less frequent in unaffected than in affected dogs and in affected dogs post-2001 than pre-2001. The ATP7B mutation was more frequent in affected than unaffected Bedlingtons. Thirty-five of 144 dogs of other breeds were homo- or heterozygous for the ATP7B mutation. The ATP7A mutation was absent from Bedlingtons. LIMITATIONS: Clinical information and qualitative copper measurements were unavailable for most dogs. CONCLUSION: The COMMD1 deletion remains present in Bedlington terriers but is no longer the primary cause of CT. ABCA12 SNPs were not associated with CT. The ATP7B:c.4358G>A mutation was significantly associated with Bedlington CT and was more common in dogs of this breed than in the 144 dogs of other breeds.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/37038639/